These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27524626)

  • 1. Structure of Gremlin-2 in Complex with GDF5 Gives Insight into DAN-Family-Mediated BMP Antagonism.
    Nolan K; Kattamuri C; Rankin SA; Read RJ; Zorn AM; Thompson TB
    Cell Rep; 2016 Aug; 16(8):2077-2086. PubMed ID: 27524626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis and identification of the Grem2 heparin/heparan sulfate-binding motif.
    Kattamuri C; Nolan K; Thompson TB
    Biochem J; 2017 Mar; 474(7):1093-1107. PubMed ID: 28104757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of Gremlin-1 and analysis of its interaction with BMP-2.
    Kišonaitė M; Wang X; Hyvönen M
    Biochem J; 2016 Jun; 473(11):1593-604. PubMed ID: 27036124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of protein related to Dan and Cerberus: insights into the mechanism of bone morphogenetic protein antagonism.
    Nolan K; Kattamuri C; Luedeke DM; Deng X; Jagpal A; Zhang F; Linhardt RJ; Kenny AP; Zorn AM; Thompson TB
    Structure; 2013 Aug; 21(8):1417-29. PubMed ID: 23850456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists.
    Nolan K; Kattamuri C; Luedeke DM; Angerman EB; Rankin SA; Stevens ML; Zorn AM; Thompson TB
    J Biol Chem; 2015 Feb; 290(8):4759-4771. PubMed ID: 25561725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the molecular mechanism of multiple synostoses syndrome (SYNS): mutation within the GDF5 knuckle epitope causes noggin-resistance.
    Schwaerzer GK; Hiepen C; Schrewe H; Nickel J; Ploeger F; Sebald W; Mueller T; Knaus P
    J Bone Miner Res; 2012 Feb; 27(2):429-42. PubMed ID: 21976273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of BMP-2 and BMP-7 interactions with antagonists Gremlin-1 and Noggin in Glioblastoma tumors.
    Choudhuri KSR; Mishra S
    J Comput Chem; 2020 Nov; 41(30):2544-2561. PubMed ID: 32935366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulosal and thecal expression of bone morphogenetic protein- and activin-binding protein mRNA transcripts during bovine follicle development and factors modulating their expression in vitro.
    Glister C; Satchell L; Knight PG
    Reproduction; 2011 Oct; 142(4):581-91. PubMed ID: 21821720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repulsive guidance molecules lock growth differentiation factor 5 in an inhibitory complex.
    Malinauskas T; Peer TV; Bishop B; Mueller TD; Siebold C
    Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15620-15631. PubMed ID: 32576689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb.
    Merino R; Rodriguez-Leon J; Macias D; Gañan Y; Economides AN; Hurle JM
    Development; 1999 Dec; 126(23):5515-22. PubMed ID: 10556075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the heparin-binding site of the BMP antagonist gremlin by site-directed mutagenesis based on predictive modelling.
    Tatsinkam AJ; Mulloy B; Rider CC
    Biochem J; 2015 Aug; 470(1):53-64. PubMed ID: 26251446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gremlin1 preferentially binds to bone morphogenetic protein-2 (BMP-2) and BMP-4 over BMP-7.
    Church RH; Krishnakumar A; Urbanek A; Geschwindner S; Meneely J; Bianchi A; Basta B; Monaghan S; Elliot C; Strömstedt M; Ferguson N; Martin F; Brazil DP
    Biochem J; 2015 Feb; 466(1):55-68. PubMed ID: 25378054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.
    Tardif G; Hum D; Pelletier JP; Boileau C; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2004 Aug; 50(8):2521-30. PubMed ID: 15334466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities.
    Hsu DR; Economides AN; Wang X; Eimon PM; Harland RM
    Mol Cell; 1998 Apr; 1(5):673-83. PubMed ID: 9660951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the different oligomeric states of the DAN family antagonists SOSTDC1 and SOST.
    Gipson GR; Kattamuri C; Czepnik M; Thompson TB
    Biochem J; 2020 Sep; 477(17):3167-3182. PubMed ID: 32779697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of direct negative cross-talk between the SLIT2 and bone morphogenetic protein-Gremlin signaling pathways.
    Tumelty KE; Higginson-Scott N; Fan X; Bajaj P; Knowlton KM; Shamashkin M; Coyle AJ; Lu W; Berasi SP
    J Biol Chem; 2018 Mar; 293(9):3039-3055. PubMed ID: 29317497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Members of the DAN family are BMP antagonists that form highly stable noncovalent dimers.
    Kattamuri C; Luedeke DM; Nolan K; Rankin SA; Greis KD; Zorn AM; Thompson TB
    J Mol Biol; 2012 Dec; 424(5):313-27. PubMed ID: 23063586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the Dual-Mode Wnt Regulator Kremen1 and Insight into Ternary Complex Formation with LRP6 and Dickkopf.
    Zebisch M; Jackson VA; Zhao Y; Jones EY
    Structure; 2016 Sep; 24(9):1599-605. PubMed ID: 27524201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into BMP-7 mediated osteoblastic differentiation of primary human mesenchymal stem cells.
    Lavery K; Hawley S; Swain P; Rooney R; Falb D; Alaoui-Ismaili MH
    Bone; 2009 Jul; 45(1):27-41. PubMed ID: 19306956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts.
    Pereira RC; Economides AN; Canalis E
    Endocrinology; 2000 Dec; 141(12):4558-63. PubMed ID: 11108268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.